Femodene ED

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Ethinylestradiol 0.03mg; Gestodene 0.075mg

Disponible depuis:

Bayer New Zealand Limited

DCI (Dénomination commune internationale):

Ethinylestradiol 0.03 mg

forme pharmaceutique:

Tablet

Composition:

Active: Ethinylestradiol 0.03mg Gestodene 0.075mg Excipient: Calcium carbonate Glycol montanate Lactose monohydrate Macrogol 6000 Magnesium stearate Maize starch Povidone   Purified talc Sodium calcium edetate Sucrose Lactose monohydrate

Unités en paquet:

Blister pack, 2x (21 + 7), 56 tablets

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

Bayer AG

Descriptif du produit:

Package - Contents - Shelf Life: Blister pack, 2x (21 + 7) - 56 tablets - 60 months from date of manufacture stored at or below 25°C - Calendar pack, 1x (21 + 7) - 28 tablets - 60 months from date of manufacture stored at or below 25°C - Calendar pack, 3 x (21 + 7) - 84 tablets - 60 months from date of manufacture stored at or below 25°C

Date de l'autorisation:

1987-12-21